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httpicense.Abstract Aim of work: To evaluate the role of three dimensional (3D), two dimensional (2D) as
well as power Doppler transrectal ultrasound (TRUS) in diagnosis of different prostatic lesions.
Patients and methods: 2-D TRUS, power Doppler and Transrectal 3-D US were performed for 100
patients between April 2009 and April 2010. All patients had been examined clinically with digital
rectal examination (DRE) and had serum prostatic speciﬁc antigen (PSA) level (total and free).
Patient age ranges from 42 to 67 years and the mean age was 55 years. TRUS guided biopsies were
done for 77 cases showing any of the followings: abnormal focal lesion with ultrasound, abnormal
vascularity with power Doppler exam, abnormal DRE, elevated serum total PSA >4 ng/ml or
when the percent-free PSA is 10% or less in an outpatient setting. The results were recorded and
analyzed.
Results: 3-D TRUS was more sensitive, speciﬁc and more accurate than 2-D TRUS in detecting
prostate cancer as it showed estimated sensitivity 78.9% and speciﬁcity 94.8% with total accuracy
90.9% with respect to an estimated sensitivity 63.1%, speciﬁcity 86.2% and total accuracy 80.5%
with 2-D TRUS and was more accurate than 2-D ultrasound in identifying the capsular breaks with
an estimated sensitivity 80% with respect to 40% with 2-D TRUS.
Power Doppler showed 84.2% sensitivity in detecting prostatic cancer and was of 100% sensitivity
in detecting prostatitis. 3-D TRUS was more accurate in estimating the volume of adenoma in cases
of BPH with an estimated error not more than +6% with respect to an estimated error not more
than +18% for 2-D TRUS.0846371195, mobile: +20
m (A. Talaat Youssef).
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466 A. Talaat Youssef, K.M. EldenConclusion: 3-D transrectal ultrasound and power Doppler sonography have speciﬁc diagnostic
capabilities which added signiﬁcantly to the ultrasound in detecting and staging of prostatic cancer
and in the planning for management .They proved highly valuable in the diagnosis of prostatitis and
3-D TRUS was more accurate than 2-D TRUS in estimating the volume of adenomas in patients
with BPH.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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Watanabe et al. ﬁrst introduced TRUS as a clinical investiga-
tion for prostate evaluation, since that date and with advance-
ment of ultrasound technology TRUS, became the standard
imaging modality for prostatic diseases (1,2). The advances
in ultrasound technology machines, particularly the progress
in the high frequency transducers, advancement in computer
technology and Doppler techniques, made TRUS more reli-
able for prostate cancers detection (3).
Prostate cancer does not have a uniform appearance on the
ordinary two dimension 2-D gray scale images, as malignan-
cies located in the outer (peripheral and central zones) or inner
(transition zone) gland have different histologic and biologic
appearances so this will be reﬂected differently on US images
(4).
Three dimensional 3-D TRUS demonstrate the anatomic
delineation of the prostate and lesions within it and demarcate
the structures around the prostate, in three planes simulta-
neously, the sagittal plane, horizontal (or axial) plane, as well
the coronal plane. This enables the physician to reproduce a
high resolution image of three dimensions on the US monitor
or personal computer in few seconds (3,5).
3-D TRUS allows better assessment of prostate size and its
internal zones improve the biopsy yield during transrectal
biopsy and increase the sensitivity and speciﬁcity for prostate
cancer detection over the traditional 2-D gray scale ultra-
sound. Also it measures accurately the tumor size thus helps
in the plane of treatment and the follow up, this improves
the outcome and reduces the side effects (6–9).
Color Doppler sonography increases the sensitivity of ultra-
sound in the detection of prostatic cancer by increasing the
positive predictive value from 53% to 77% and in other series
it became 80.6% however the presence of inﬂammation can
increase the false positive rate because of associated hyperemia
(3,10). The combination of power Doppler with 3-D TRUS in-
creases the rate of cancer detection with optimization of biopsy
cores as it helps in targeting areas presenting with abnormal
blood ﬂow. Also it helps in detection of extracapsular inﬁltra-
tion by detecting perforating vessels in the capsule with overall
accuracy of 92% (11).
2. Aim of work
To evaluate the role of three dimensional (3D), two dimen-
sional (2D) as well as power Doppler transrectal ultrasound
(TRUS) in diagnosis of different prostatic lesions.
3. Patients and methods
2-D TRUS, power Doppler sonography and 3D TRUS were
performed for 100 patients between April 2009 and April2010. All patients were referred from urology department
and were complaining of lower urinary tract obstructive or
irritative symptoms and underwent history taken with interna-
tional prostatic symptoms score (IPSS) sheet and or they had
abnormal digital rectal examination (DRE) and or they had
elevated serum prostatic speciﬁc antigen (PSA) level. Patient
age ranges from 42 to 67 years and the mean age was 55 years.
The patient was examined in left lateral decubitus
knee-chest position (11), using 3-D mechanical high frequency
transrectal volume probe, GE logiq 7 ultrasonic machine
(Milwaukee, WI, USA).
The volume estimation of prostate with 2-D transrectal
ultrasonography was done by an ellipsoidal volume calcula-
tion. The prostate is considered ellipsoidal in shape and the
volume (mL) is 0.523 · width (cm) · height (cm) · length
(cm), (the widths and heights were measured on axial planes
and craniocaudal length on sagittal plane at their greatest
diameter), while with 3D we use the 2 plane contour method
(2,6).
Consequently the entire gland and its periprostatic tissues
(especially fat planes in apical region, and middle lobe in large
glands) were examined from apex to base including the seminal
vesicles. Gray scale sagittal scanning was then performed from
left to right. Every abnormality imaged in both axial and sag-
ittal planes (12,13).
Power Doppler interrogation was performed in the axial
plane from apex to base. The color window must cover the en-
tire gland. Finally, biopsies were performed for 77 cases show-
ing suspicious areas within the prostate during 2-D,3-D
TRUS, abnormal ﬂow pattern with power Doppler sonogra-
phy and for cases with abnormal DRE or elevated serum total
PSA >4 ng/ml or when the percent-free PSA is 10% or less
after taking patient consent. The patients were instructed to
take antibiotics before and after the procedure, to stop any
anticoagulants or non steroidal anti-inﬂammatory drugs and
to do an enema before the procedure. Eight tissue samples
were taken from different prostatic regions (6 tissue samples
were taken from the midlobe parasagittal planes bilaterally
at the base, middle and apical prostatic zones and 2 samples
from the lateral aspect of each lobe) in addition tissue samples
were taken from the suspicious focal lesions or from the sem-
inal vesicles suspected tumor inﬁlteration observed during
transrectal ultrasound. TRUS and TRUS guided biopsy were
performed in an outpatient setting.
We started the examination by 2D transrectal ultrasound
followed by power Doppler ultrasonography to the region of
interest to evaluate the presence of hyperemia and there after
the 3D ultrasound was activated and the region of interest
was scanned with subsequent multiplanar image analysis and
surface rendering. 2-D TRUS, power Doppler and 3-D TRUS
exams were done by blind operator to the data received from
the DRE and PSA serum level.
Table 2 Accuracy of 2-D TRUS in detecting biopsy proved
prostatic cancer.
Sensitivity 63.1%
Speciﬁcity 86.2%
+ve predictive value 60.0%
ve predictive value 87.7%
Total accuracy 80.5%
P-value =<0.0001.
Sensitivity: true positive rate (TPR) = diseased with positive test/
all diseased.
Speciﬁcity: true negative rate (TNR) = disease free with negative
test/all disease free.
False positive rate (FPR): disease free with positive test/all disease
free.
Positive predictive value (PPV): diseased with positive test/all with
positive test.
Negative predictive value (NPV): disease free with negative test/all
with negative test.
Table 3 Summarizes the results of 3-D TRUS in detecting
biopsy proved prostatic cancer.
Biopsy Total
+ve ve
3_D TRUS
+ve 15 (TP) 3 (FP) 18 (all test positive)
ve 4 (FN) 55 (TN) 59 (all test negative)
Total 19 (all diseased) 58 (all disease free) 77 (grand total)
Table 4 Accuracy of 3-D TRUS in detecting biopsy proved
prostatic cancer.
Sensitivity 78.9%
Speciﬁcity 94.8%
+ve predictive value 83.3%
ve predictive value 93.2%
Total accuracy 90.9%
P-value =< 0.0001.
Table 5 Comparison between the sensitivity of 2-D TRUS
and 3-D TRUS in staging of biopsy proven prostatic cancer.
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was reached from the pathological reports of guided biopsies
and from the postoperative ﬁnal pathological analysis after
radical prostatectomy. Estimation of adenomata volume with
2-D and 3-D TRUS was compared with the estimated ade-
noma volume after transurethral resection of prostate or open
prostatectomy in cases with BPH. An estimated% error in vol-
ume calculation of adenoma using 2-D and 3-D TRUS was
calculated by dividing the difference between the estimated
2-D or 3-D ultrasound volume and the estimated postopera-
tive volume of adenoma/postoperative volume of adenoma.
Statistical analysis of data: The collected data were orga-
nized, tabulated and statistically analyzed using SPSS software
statistical computer package version 15 (SPSS Inc., USA). Chi
(X2) square was used as a test of signiﬁcance of the accuracy of
2D and 3D TRUS in diagnosing prostatic cancer. Signiﬁcance
was adopted at P< 0.05.
4. Results
2-D Transrectal US aided with power Doppler and 3-D TRUS
were performed for 100 patients, over the period of 1 year, the
ﬁnal diagnosis was reached in 77 patients.
Eighteen patients showed prostatic carcinomas, one patient
showed prostatic sarcoma. All proved with biopsy. 38 patients
showed benign prostatic hyperplasia (BPH). Twenty patients
diagnosed as prostatitis.
In patients with biopsy proved prostatic cancer 3-D TRUS
showed estimated sensitivity 78.9% and speciﬁcity 94.8% with
total accuracy 90.9% (Tables 3 and 4) with respect to an esti-
mated sensitivity 63.1%, speciﬁcity 86.2% and total accuracy
80.5% with 2-D TRUS (Tables 1 and 2).
3-D TRUS clearly identiﬁes the extraprostatic spread to the
periprostatic fat in 3 patients, inﬁltration to the seminal vesi-
cles in 3 patients, inﬁltration to the base of urinary bladder
in 2 patients and also the presence of capsular breaks in 4
patients out of 5 proved from the pathological reports after
radical prostatectomy conﬁrm that the lesion is totally intra
glandular in 6 patients.
The results were equivocal or negative in 3 patients by 2D
ultrasonography for detecting intra glandular lesions and were
negative in detecting capsular breaks in 3 patients out of 5
proved by biopsy but it was able to detect all patients with
inﬁltration to the periprostatic fat planes and the base of uri-
nary bladder in 2 patients out of 3 with seminal vesicles inﬁl-
tration (Table 5). Both techniques failed to diagnose 2
patients with biopsy proved transitional zone carcinoma andTable 1 Summarizes the results of 2-D TRUS in detecting
biopsy proved prostatic cancer.
Biopsy Total
+ve ve
2-D TRUS
+ve 12 (TP) 8 (FP) 20 (all test positive)
ve 7 (FN) 50 (TN) 57 (all test negative)
Total 19 (all diseased) 58 (all disease free) 77 (grand total)
TP = true positive.
FP = false positive.
FN= false negative.
TN= true negative.
Lesions Sensitivity%
of 2-D TRUS
Sensitivity%
of 3-D TRUS
Capsular breaks 40.0 80.0
Spread to extra prostatic fat 100.0 100.0
Inﬁltration to urinary bladder 100.0 100.0
Inﬁltration to seminal vesicles 67.0 100.0
Intra glandular lesions 50.0 100.02 patients with localized intra glandular peripheral zone le-
sions, possibly due to the isoechoic nature of the lesions in
the later.
In patients with benign prostatic hyperplasia (BPH), the
postoperative data after transurethral resection of prostatic
Fig. 1 3-D Transrectal US reconstruction with volume rendering
of normal prostate.
Fig. 2 2-D TRUS (A) and 3-D TRUS (B) images for
Fig. 3 2-D TRUS (A) coronal reformation (B) 3-D TRUS multipla
periprostatic fat planes.
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2-D and 3-D TRUS results showed that 3-D TRUS was supe-
rior to 2-D ultrasonography in calculating the volume of ade-
nomas with an estimated error not more than ±6% with
regard to an estimated error not more than ±18% for 2-D
TRUS. 3-D ultrasound showed excellent delineation of the
transitional zone especially in the coronal plane which is the
blind plane for 2-D ultrasonography.
In patients with acute prostatitis the combination of
power Doppler US and 2D ultrasonography or 3D ultraso-
nography gave better results than the use of 2D or 3D TRUS
alone. Power Doppler US helped in identifying the hyperae-
mic prostatic foci and we suggest that the presence of peri-
urethral zone of hyperemia and irregular lucency is the most
valuable sign for inﬂammatory group (seen in all of our 20
patients) as well as the presence of congested periprostatic
venous plexus.prostate cancer with focal areas of capsular breaks.
nar image analysis (C) showing prostate cancer with extension to
Fig. 4 2-D TRUS (A) and 3-D reconstruction (B) of transitional zone carcinoma with extension to the periprostatic fat planes.
Fig. 5 3-D power Doppler of prostate cancer.
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Benign prostatic hyperplasia mainly involves the inner gland
and showed heterogenous echotexture by US. The glandular
hyperplasia showed echogenic texture, while stromal hyperpla-
sia appears hypoechoic (14).
3-D TRUS offers high resolution volume rendering image
to the prostate (Fig. 1) and is highly valuable in patients withFig. 6 2-D TRUS study of prostate with BPH showing eBPH as it offers excellent delineation to the transitional zone
by the coronal scan and the accurate volume estimation with
an estimated error not more than ±6% with respect to an esti-
mated error not more than ±18% with 2-D TRUS in volume
calculation as shown in our study which allows for the opti-
mum decision of management whether surgical (open or endo)
or nonsurgical (Figs. 6 and 7). Also with introduction of laser
therapy for BPH, it allows for accurate guided placements of
laser ﬁbers within the transitional zone which is an advantage
cannot be offered by 2D ultrasound (15).
Patients with prostatic cancer areas suspicious of cancer
were seen as hypoechoic (in some cases it became isoechoic
or hyperechoic) or as glandular asymmetry. Suspicious of
extracapsular disease is seen as a disruption of the peripros-
tatic fat layer in association with a hypoechoic lesion; and sus-
picious of seminal vesicle invasion appears as obliteration of
the angle between the seminal vesicle and the base of the pros-
tate, or continuation of the hypoechoic lesion into the seminal
vesicles (3,4,7,8).
The traditional 2-D ultrasound uses two-dimensional tech-
nique to visualize a three dimension disease process with re-
ported sensitivity in staging the prostatic cancer varying
from 50% to 90% (16) and in some series 2-D TRUS adds
little advantages over the digital rectal examination.nlarged transitional zone with intra vesical protrusion.
Fig. 7 3-D TRUS multiplanar image analysis showing enlarged middle lobe with intra vesical protrusion in patient with BPH.
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staging prostate cancer with sensitivity of 80% and speciﬁcity
of 96% in a pilot study. Strasser et al. reported that 3-D TRUS
was 87% sensitive and 94% speciﬁc for extracapsular exten-
sion of prostate cancer (18). In our current study 3-D TRUS
was more sensitive, speciﬁc and more accurate than 2-D TRUS
in detecting prostate cancer as it showed estimated sensitivity
78.9% and speciﬁcity 94.8% with total accuracy 90.9% with
respect to an estimated sensitivity 63.1%, speciﬁcity 86.2%
and total accuracy 80.5% with 2-D TRUS and was more accu-
rate than 2-D ultrasound in identifying the capsular breaksFig. 8 2D TRUS (A), directional power Doppler study (B) and 3-D
lucency and hyperemia suggesting of prostatitis.(Fig. 2A and B) which is expected due to the much higher im-
age resolution especially in 3-D volume rendering images and
the precise delineation of the prostatic zones and the peripros-
tatic structures in multiplanar image analysis. 3-D TRUS was
highly sensitive in detecting inﬁltration to the urinary bladder
base, seminal vesicles and periprostatic fat planes (Figs. 3 and
4).It was of less accuracy in identifying the intra prostatic
cancer either due to lesions involving the transitional zone or
the isoechoic nature of the lesions involving the peripheral
zone. However it was more sensitive than 2-D TRUS in
identifying the intra glandular lesions.reconstruction (C) showing periurethral zone accentuated halo of
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more accurate than 2D TRUS in staging the prostate cancer
and detection of capsular breaks as the presence of capsular
breaks increases the chance for post radical prostatectomy
recurrence. Based on its accurate volume calculations 3-D
TRUS can also give the volume of malignant lesion which
helps in post hormonal therapy follow up. Previous studies
showed that 3-D TRUS was of great beneﬁts in guided biop-
sies as it allows accurate targeting of prostatic lesions. Also
the feasibility of 3-D TRUS to assess the probe placement in
cryoablation of localized prostatic cancer in patients unsuit-
able for surgery was well recognized (19).
The introduction of power Doppler aided TRUS added sig-
niﬁcantly to the diagnosis of prostate cancer, Sauvain et al.
investigated 323 men, 282 with suspected cancer, 92.3% of
cancers showed abnormal ﬂow and 7.7% showed no measur-
able ﬂow. If a hypoechoic lesion seen on gray scale US had in-
creased blood ﬂow the risk of positive prostatic biopsy was
81% while the lesion is hypovascular the risk was 14% (20).
In our current study 16 patients out of 19 with biopsy
proved prostatic cancer showed abnormal blood ﬂow pattern
(Fig. 5) with an estimated sensitivity of power Doppler 84.2%.
For patients with acute prostatitis power Doppler sonogra-
phy in our current study was 100% sensitive in the detection of
the disease and added signiﬁcantly to the accuracy of 2-D
ultrasonography in the diagnosis. The presence of periurethal
hyperemia and congested peri prostatic venous plexus were
the most helpful criteria in diagnosis (Fig. 8). Venziano et al.
reported increased vascularity in cases with prostatitis matched
with the severity of symptoms (21).
Our main limitation during the study that we did not have a
wide number of patients for each speciﬁc prostatic disease as
we were dependent only on the patients who attended to our
hospital and so we recommend further studies which correlate
the image ﬁndings with the pathological results in a large num-
ber of patients with speciﬁc prostatic disease.
6. Conclusion
3-D Transrectal ultrasound and power Doppler sonography
have speciﬁc diagnostic capabilities which added signiﬁcantly
to the ultrasound in detecting and staging of prostatic cancer
and in the planning for management. They proved highly valu-
able in the diagnosis of prostatitis and 3-D TRUS was more
accurate than 2-D TRUS in estimating the volume of adeno-
mas in patients with BPH.
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